← Back to patent-cliff list
CAS 62566-66-9
(R)-2-(2-chlorophenyl)oxirane
Codes: CENO-001
Application context (from source-drug indications)
Partial-onset seizureCenobamateEpilepsyCenobamateSeizureCenobamateGeneralised epilepsyCenobamateHepatic function declineCenobamate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Cenobamate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(R)-2-(2-chlorophenyl)oxirane→1H-tetrazole
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2-Bromo-2'-chloroacetophenone Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | 1-(2-chlorophenyl)-2-(1,2,3,4-tetrazol-2-yl)ethan-1-one Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | Cenobamate N-1 intermediate Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.